324 related articles for article (PubMed ID: 20337001)
41. Sugammadex: a novel agent for the reversal of neuromuscular blockade.
Nicholson WT; Sprung J; Jankowski CJ
Pharmacotherapy; 2007 Aug; 27(8):1181-8. PubMed ID: 17655516
[TBL] [Abstract][Full Text] [Related]
42. Efficacy of sugammadex for the reversal of moderate and deep rocuronium-induced neuromuscular block in patients pretreated with intravenous magnesium: a randomized controlled trial.
Czarnetzki C; Tassonyi E; Lysakowski C; Elia N; Tramèr MR
Anesthesiology; 2014 Jul; 121(1):59-67. PubMed ID: 24608361
[TBL] [Abstract][Full Text] [Related]
43. Sugammadex: another milestone in clinical neuromuscular pharmacology.
Naguib M
Anesth Analg; 2007 Mar; 104(3):575-81. PubMed ID: 17312211
[TBL] [Abstract][Full Text] [Related]
44. Do we really need sugammadex as an antagonist of muscle relaxants in anesthesia?
Meistelman C; Donati F
Curr Opin Anaesthesiol; 2016 Aug; 29(4):462-7. PubMed ID: 27168088
[TBL] [Abstract][Full Text] [Related]
45. Use of Sugammadex in Patients With Obesity: A Pooled Analysis.
Monk TG; Rietbergen H; Woo T; Fennema H
Am J Ther; 2017; 24(5):e507-e516. PubMed ID: 26398716
[TBL] [Abstract][Full Text] [Related]
46. Rocuronium and sugammadex in patients with myasthenia gravis undergoing thymectomy.
Sungur Ulke Z; Yavru A; Camci E; Ozkan B; Toker A; Senturk M
Acta Anaesthesiol Scand; 2013 Jul; 57(6):745-8. PubMed ID: 23678983
[TBL] [Abstract][Full Text] [Related]
47. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine.
Jones RK; Caldwell JE; Brull SJ; Soto RG
Anesthesiology; 2008 Nov; 109(5):816-24. PubMed ID: 18946293
[TBL] [Abstract][Full Text] [Related]
48. Urgent usage of sugammadex to treat residual neuromuscular blockade in the PACU.
Jones PM; Turkstra TP
Anesth Analg; 2007 Sep; 105(3):877; author reply 878. PubMed ID: 17717257
[No Abstract] [Full Text] [Related]
49. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients.
Plaud B; Meretoja O; Hofmockel R; Raft J; Stoddart PA; van Kuijk JH; Hermens Y; Mirakhur RK
Anesthesiology; 2009 Feb; 110(2):284-94. PubMed ID: 19194156
[TBL] [Abstract][Full Text] [Related]
50. A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery.
Geldner G; Niskanen M; Laurila P; Mizikov V; Hübler M; Beck G; Rietbergen H; Nicolayenko E
Anaesthesia; 2012 Sep; 67(9):991-8. PubMed ID: 22698066
[TBL] [Abstract][Full Text] [Related]
51. Assessment of the potential for displacement interactions with sugammadex: a pharmacokinetic-pharmacodynamic modelling approach.
Zwiers A; van den Heuvel M; Smeets J; Rutherford S
Clin Drug Investig; 2011; 31(2):101-11. PubMed ID: 21067251
[TBL] [Abstract][Full Text] [Related]
52. Rocuronium-induced neuromuscular block and sugammadex in pediatric patient with duchenne muscular dystrophy: A case Report.
Kim JE; Chun HR
Medicine (Baltimore); 2017 Mar; 96(13):e6456. PubMed ID: 28353578
[TBL] [Abstract][Full Text] [Related]
53. Sugammadex: the first selective binding reversal agent for neuromuscular block.
Kovac AL
J Clin Anesth; 2009 Sep; 21(6):444-53. PubMed ID: 19833281
[TBL] [Abstract][Full Text] [Related]
54. [Extremely prolonged neuromuscular block after a single dose of rocuronium].
Menouni O; Brillouet-Banchereau AC; Galan G; Lélias A; Sautereau A; Gadrey S
Ann Fr Anesth Reanim; 2011 Nov; 30(11):841-3. PubMed ID: 21983058
[TBL] [Abstract][Full Text] [Related]
55. Sugammadex reversal of rocuronium-induced neuromuscular block in Caesarean section patients: a series of seven cases.
Pühringer FK; Kristen P; Rex C
Br J Anaesth; 2010 Nov; 105(5):657-60. PubMed ID: 20736231
[TBL] [Abstract][Full Text] [Related]
56. Time course of action of sugammadex (Org 25969) on rocuronium-induced block in the Rhesus monkey, using a simple model of equilibration of complex formation.
de Boer HD; van Egmond J; van de Pol F; Bom A; Driessen JJ; Booij LH
Br J Anaesth; 2006 Nov; 97(5):681-6. PubMed ID: 17018564
[TBL] [Abstract][Full Text] [Related]
57. The Use of Sugammadex in a Patient With Guillain-Barre Syndrome: A Case Report.
Tezcan B; Bölükbaşi D; Kazanci D; Turan S; Suer Kaya G; Özgök A
A A Case Rep; 2017 Apr; 8(8):200-202. PubMed ID: 28151766
[TBL] [Abstract][Full Text] [Related]
58. The Myth of Rescue Reversal in "Can't Intubate, Can't Ventilate" Scenarios.
Naguib M; Brewer L; LaPierre C; Kopman AF; Johnson KB
Anesth Analg; 2016 Jul; 123(1):82-92. PubMed ID: 27140684
[TBL] [Abstract][Full Text] [Related]
59. Optimizing Reversal of Neuromuscular Block in Older Adults: Sugammadex or Neostigmine.
Togioka BM; Schenning KJ
Drugs Aging; 2022 Oct; 39(10):749-761. PubMed ID: 35934764
[TBL] [Abstract][Full Text] [Related]
60. Efficacy, safety, and pharmacokinetics of sugammadex for the reversal of rocuronium-induced neuromuscular blockade in elderly patients.
McDonagh DL; Benedict PE; Kovac AL; Drover DR; Brister NW; Morte JB; Monk TG
Anesthesiology; 2011 Feb; 114(2):318-29. PubMed ID: 21239968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
